Anti-CD133 Antibody Market Report – Research, Industry Analysis Reports and Market Demands

Global Anti-CD133 Antibody Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-CD133 Antibody by Type
- 1.3.1 Overview: Global Anti-CD133 Antibody Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Anti-CD133 Antibody Consumption Value Market Share by Type in 2025
- 1.3.3 Monoclonal Antibody
- 1.3.4 Polyclonal Antibody
1.4 Global Anti-CD133 Antibody Market by Application
- 1.4.1 Overview: Global Anti-CD133 Antibody Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Biotechnology
- 1.4.3 Medical
- 1.4.4 University
- 1.4.5 Others
1.5 Global Anti-CD133 Antibody Market Size & Forecast
1.6 Global Anti-CD133 Antibody Market Size and Forecast by Region
- 1.6.1 Global Anti-CD133 Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Anti-CD133 Antibody Market Size by Region, (2021-2032)
- 1.6.3 North America Anti-CD133 Antibody Market Size and Prospect (2021-2032)
- 1.6.4 Europe Anti-CD133 Antibody Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Anti-CD133 Antibody Market Size and Prospect (2021-2032)
- 1.6.6 South America Anti-CD133 Antibody Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Anti-CD133 Antibody Market Size and Prospect (2021-2032)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Anti-CD133 Antibody Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Anti-CD133 Antibody by Company Revenue
- 3.2.2 Top 3 Anti-CD133 Antibody Players Market Share in 2025
- 3.2.3 Top 6 Anti-CD133 Antibody Players Market Share in 2025
3.3 Anti-CD133 Antibody Market: Overall Company Footprint Analysis
- 3.3.1 Anti-CD133 Antibody Market: Region Footprint
- 3.3.2 Anti-CD133 Antibody Market: Company Product Type Footprint
- 3.3.3 Anti-CD133 Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Anti-CD133 Antibody Consumption Value and Market Share by Type (2021-2026)
4.2 Global Anti-CD133 Antibody Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Anti-CD133 Antibody Consumption Value Market Share by Application (2021-2026)
5.2 Global Anti-CD133 Antibody Market Forecast by Application (2027-2032)

6 North America

6.1 North America Anti-CD133 Antibody Consumption Value by Type (2021-2032)
6.2 North America Anti-CD133 Antibody Market Size by Application (2021-2032)
6.3 North America Anti-CD133 Antibody Market Size by Country
- 6.3.1 North America Anti-CD133 Antibody Consumption Value by Country (2021-2032)
- 6.3.2 United States Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 6.3.3 Canada Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Anti-CD133 Antibody Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Anti-CD133 Antibody Consumption Value by Type (2021-2032)
7.2 Europe Anti-CD133 Antibody Consumption Value by Application (2021-2032)
7.3 Europe Anti-CD133 Antibody Market Size by Country
- 7.3.1 Europe Anti-CD133 Antibody Consumption Value by Country (2021-2032)
- 7.3.2 Germany Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 7.3.3 France Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 7.3.5 Russia Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 7.3.6 Italy Anti-CD133 Antibody Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Anti-CD133 Antibody Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Anti-CD133 Antibody Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Anti-CD133 Antibody Market Size by Region
- 8.3.1 Asia-Pacific Anti-CD133 Antibody Consumption Value by Region (2021-2032)
- 8.3.2 China Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 8.3.3 Japan Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 8.3.5 India Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 8.3.7 Australia Anti-CD133 Antibody Market Size and Forecast (2021-2032)

9 South America

9.1 South America Anti-CD133 Antibody Consumption Value by Type (2021-2032)
9.2 South America Anti-CD133 Antibody Consumption Value by Application (2021-2032)
9.3 South America Anti-CD133 Antibody Market Size by Country
- 9.3.1 South America Anti-CD133 Antibody Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Anti-CD133 Antibody Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Anti-CD133 Antibody Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Anti-CD133 Antibody Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Anti-CD133 Antibody Market Size by Country
- 10.3.1 Middle East & Africa Anti-CD133 Antibody Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Anti-CD133 Antibody Market Size and Forecast (2021-2032)
- 10.3.4 UAE Anti-CD133 Antibody Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Anti-CD133 Antibody Market Drivers
11.2 Anti-CD133 Antibody Market Restraints
11.3 Anti-CD133 Antibody Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Anti-CD133 Antibody Industry Chain
12.2 Anti-CD133 Antibody Upstream Analysis
12.3 Anti-CD133 Antibody Midstream Analysis
12.4 Anti-CD133 Antibody Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Anti-CD133 Antibody market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Anti-CD133 Antibody is an antibody that specifically binds to CD133, a cell surface protein known as cluster of differentiation 133. CD133 is primarily found on stem cells, including those of the blood and epithelial tissues. This antibody is widely used in research to isolate and study stem cells, particularly in the context of cancer research, where CD133 has been associated with tumor initiating cells. It is also explored for its potential in regenerative medicine and tissue engineering due to CD133"s presence on cells with regenerative potential.
The industry trend for Anti-CD133 Antibody has seen a rise as it becomes an increasingly important tool in stem cell research and oncology. The antibody"s role in identifying and isolating cancer stem cells has implications for the development of novel therapeutics targeting these cells, which are believed to be responsible for tumor recurrence and resistance to treatment. Additionally, the potential for CD133 in regenerative applications is driving the demand for high-quality Anti-CD133 Antibody products. As research progresses and the functions of CD133 in various diseases are further understood, the industry trend for this antibody is expected to continue growing.
This report is a detailed and comprehensive analysis for global Anti-CD133 Antibody market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-CD133 Antibody market size and forecasts, in consumption value ($ Million), 2021-2032
Global Anti-CD133 Antibody market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Anti-CD133 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Anti-CD133 Antibody market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-CD133 Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-CD133 Antibody market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, GeneTex, ProSci, Bioss, Absolute Antibody, MyBioSource, Biorbyt, Thermo Fisher Scientific, R&D Systems, Novus Biologicals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anti-CD133 Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibody
Polyclonal Antibody
Market segment by Application
Biotechnology
Medical
University
Others
Market segment by players, this report covers
BosterBio
GeneTex
ProSci
Bioss
Absolute Antibody
MyBioSource
Biorbyt
Thermo Fisher Scientific
R&D Systems
Novus Biologicals
BioLegend
G Biosciences
Cell Signaling Technology
RayBiotech
HUABIO
Abeomics
Proteintech Group
Miltenyi Biotec
Wuhan Fine Biotech
NSJ Bioreagents
Bethyl Laboratories
OriGene Technologies
Signalway Antibody
Abnova
Bioassay Technology Laboratory
AAT Bioquest
Sino Biological
ProteoGenix
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-CD133 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-CD133 Antibody, with revenue, gross margin, and global market share of Anti-CD133 Antibody from 2021 to 2026.
Chapter 3, the Anti-CD133 Antibody competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Anti-CD133 Antibody market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-CD133 Antibody.
Chapter 13, to describe Anti-CD133 Antibody research findings and conclusion.

Buy now